Pharmagen Net Receivables vs Common Stock Analysis

PHRX Stock

USD 0.0001 0.00 0.00%

Pharmagen financial indicator trend analysis is much more than just breaking down Pharmagen prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pharmagen is a good investment. Please check the relationship between Pharmagen Net Receivables and its Common Stock accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharmagen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Pharmagen Stock please use our How to Invest in Pharmagen guide.

Net Receivables vs Common Stock

Net Receivables vs Common Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pharmagen Net Receivables account and Common Stock. At this time, the significance of the direction appears to have strong relationship.

The correlation between Pharmagen's Net Receivables and Common Stock is 0.74. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Common Stock in the same time period over historical financial statements of Pharmagen, assuming nothing else is changed. The correlation between historical values of Pharmagen's Net Receivables and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Pharmagen are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Net Receivables i.e., Pharmagen's Net Receivables and Common Stock go up and down completely randomly.

Correlation Coefficient

0.74

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Net Receivables

Common Stock

Most indicators from Pharmagen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pharmagen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharmagen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Pharmagen Stock please use our How to Invest in Pharmagen guide.Selling General Administrative is likely to rise to about 6.3 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.53 in 2024.

	2012	2013	2023	2024 (projected)
Gross Profit	1.3M	3.0M	3.5M	3.7M
Total Revenue	4.3M	4.8M	5.5M	5.8M

Gross Profit Total Revenue

Pharmagen fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Long Term Debt	Net Receivables	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Short Long Term Debt	Preferred Stock Total Equity	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment
Total Assets		0.16	0.28	-0.32	-0.42	-0.32	0.43	0.89	1.0	0.97	0.72	1.0	-0.13	0.48	0.15	0.2	0.98	0.81	0.61	0.25
Other Current Liab	0.16		0.99	-0.95	-0.92	-0.95	0.96	0.52	0.15	0.27	0.66	0.23	-0.93	0.94	1.0	1.0	0.31	0.61	0.73	1.0
Total Current Liabilities	0.28	0.99		-0.96	-0.95	-0.96	0.99	0.61	0.27	0.39	0.72	0.35	-0.93	0.98	0.99	1.0	0.42	0.69	0.78	1.0
Total Stockholder Equity	-0.32	-0.95	-0.96		0.99	1.0	-0.95	-0.68	-0.32	-0.43	-0.79	-0.4	0.96	-0.94	-0.94	-0.95	-0.47	-0.77	-0.85	-0.96
Net Tangible Assets	-0.42	-0.92	-0.95	0.99		0.99	-0.95	-0.75	-0.42	-0.52	-0.84	-0.49	0.93	-0.95	-0.92	-0.93	-0.56	-0.83	-0.88	-0.94
Retained Earnings	-0.32	-0.95	-0.96	1.0	0.99		-0.95	-0.68	-0.32	-0.43	-0.79	-0.39	0.96	-0.94	-0.94	-0.96	-0.47	-0.77	-0.85	-0.96
Accounts Payable	0.43	0.96	0.99	-0.95	-0.95	-0.95		0.72	0.42	0.53	0.79	0.49	-0.89	1.0	0.96	0.97	0.56	0.77	0.83	0.98
Cash	0.89	0.52	0.61	-0.68	-0.75	-0.68	0.72		0.89	0.93	0.93	0.93	-0.53	0.75	0.51	0.55	0.96	0.99	0.89	0.59
Long Term Debt	1.0	0.15	0.27	-0.32	-0.42	-0.32	0.42	0.89		0.95	0.73	1.0	-0.12	0.48	0.14	0.2	0.98	0.81	0.59	0.24
Net Receivables	0.97	0.27	0.39	-0.43	-0.52	-0.43	0.53	0.93	0.95		0.73	0.97	-0.3	0.57	0.27	0.31	0.99	0.85	0.74	0.36
Inventory	0.72	0.66	0.72	-0.79	-0.84	-0.79	0.79	0.93	0.73	0.73		0.78	-0.62	0.82	0.64	0.69	0.81	0.97	0.86	0.7
Other Current Assets	1.0	0.23	0.35	-0.4	-0.49	-0.39	0.49	0.93	1.0	0.97	0.78		-0.21	0.54	0.22	0.27	0.99	0.86	0.66	0.32
Other Stockholder Equity	-0.13	-0.93	-0.93	0.96	0.93	0.96	-0.89	-0.53	-0.12	-0.3	-0.62	-0.21		-0.87	-0.94	-0.93	-0.3	-0.62	-0.81	-0.93
Total Liab	0.48	0.94	0.98	-0.94	-0.95	-0.94	1.0	0.75	0.48	0.57	0.82	0.54	-0.87		0.94	0.95	0.6	0.8	0.84	0.97
Short Long Term Debt	0.15	1.0	0.99	-0.94	-0.92	-0.94	0.96	0.51	0.14	0.27	0.64	0.22	-0.94	0.94		1.0	0.3	0.6	0.73	0.99
Preferred Stock Total Equity	0.2	1.0	1.0	-0.95	-0.93	-0.96	0.97	0.55	0.2	0.31	0.69	0.27	-0.93	0.95	1.0		0.35	0.64	0.75	1.0
Total Current Assets	0.98	0.31	0.42	-0.47	-0.56	-0.47	0.56	0.96	0.98	0.99	0.81	0.99	-0.3	0.6	0.3	0.35		0.9	0.74	0.39
Intangible Assets	0.81	0.61	0.69	-0.77	-0.83	-0.77	0.77	0.99	0.81	0.85	0.97	0.86	-0.62	0.8	0.6	0.64	0.9		0.92	0.67
Common Stock	0.61	0.73	0.78	-0.85	-0.88	-0.85	0.83	0.89	0.59	0.74	0.86	0.66	-0.81	0.84	0.73	0.75	0.74	0.92		0.77
Property Plant Equipment	0.25	1.0	1.0	-0.96	-0.94	-0.96	0.98	0.59	0.24	0.36	0.7	0.32	-0.93	0.97	0.99	1.0	0.39	0.67	0.77

Click cells to compare fundamentals

Pharmagen Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Pharmagen Stock Analysis

When running Pharmagen's price analysis, check to measure Pharmagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmagen is operating at the current time. Most of Pharmagen's value examination focuses on studying past and present price action to predict the probability of Pharmagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmagen's price. Additionally, you may evaluate how the addition of Pharmagen to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Pharmagen Net Receivables vs Common Stock Analysis

Net Receivables vs Common Stock

Net Receivables vs Common Stock Correlation Analysis

Correlation Coefficient

Net Receivables

Common Stock

Pharmagen fundamental ratios Correlations

Pharmagen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Pharmagen Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Debt	+ 1.0	Total Assets
Other Current Assets	+ 1.0	Total Assets
Short Long Term Debt	+ 1.0	Other Current Liab
Preferred Stock Total Equity	+ 1.0	Other Current Liab
Property Plant Equipment	+ 1.0	Other Current Liab
Preferred Stock Total Equity	+ 1.0	Total Current Liabilities

Property Plant Equipment	- 0.96	Retained Earnings
Preferred Stock Total Equity	- 0.96	Retained Earnings
Property Plant Equipment	- 0.96	Total Stockholder Equity
Retained Earnings	- 0.96	Total Current Liabilities
Total Stockholder Equity	- 0.96	Total Current Liabilities
Accounts Payable	- 0.95	Retained Earnings